Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 847

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 847
---
 with whom transactions are prohibited or limited under any Applicable Laws pertaining to sanctions, including those administered
by the United States including, but not limited to, the United States Office of Foreign Asset Control’s Specially Designated Nationals and Blocked Persons List (“SDN List”) or the United States Department of Commerce’s
Entity List, Denied Persons List, Unverified List or Military End User List or included on comparable sanction lists of prohibited or restricted persons administered by the government of another applicable foreign jurisdiction; or (2) a person
or entity resident in, located in, or a government of a sanctioned country or territory as defined under Applicable Laws pertaining to sanctions (which currently include Belarus, Cuba, Iran, North Korea, Russia, Syria, and the Crimea, LNR, and DNR
regions of Ukraine) (“Sanctioned Country”) (collectively, a “Restricted Party”);

(aa) (i) to
WuXi Biologics’ knowledge, [***]; and

(bb) Neither the Licensed IP nor any Licensed ADC provided by WuXi Biologics under this
Agreement are sourced from a Restricted Party or a Sanctioned Country.

13.2 Representations and Warranties ofAadi. Aadi represents and warrants to WuXi Biologics that, as of [***]:

(a) Aadi is a corporation duly organized, validly
existing and is in good standing under the laws of the State of Delaware, U.S.A., is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the conduct of its business or the ownership of its
properties requires such qualification and failure to have such would prevent Aadi from performing its obligations under this Agreement;

G-26

(b) this Agreement is a legal and valid obligation binding upon Aadi and enforceable
in accordance with its terms. The execution, delivery and performance of this Agreement by Aadi have been duly authorized by all necessary corporate action and do not [***]: (i) to Aadi’s knowledge, violate any Applicable Law or award of any
court, governmental body or administrative or other agency having jurisdiction over Aadi; nor (ii) conflict with, or constitute a default under, any agreement, instrument or understanding, oral or written, to which Aadi is a party or by which
it is bound;

(c) all necessary consents, approvals and authorizations of all Regulatory Authorities, other governmental authorities
and other persons or entities required to be obtained by Aadi in order